View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Vistry Group: 1 director

A director at Vistry Group bought 23,172 shares at 1,181p and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Zhejiang Narada Power Source Co Ltd: 1 director

A director at Zhejiang Narada Power Source Co Ltd maiden bought 50,000 shares at 10.450CNY and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...

Taras Kotovych
  • Taras Kotovych

Bond Market Insight -- Reduction of UAH bond rates resumes

The NBU's decision to cut its interest rates by 100bp caused increased competition at yesterday's primary auction and led to a decrease in bond interest rates by 55‒70bp.

ABGSC Services Research ... (+3)
  • ABGSC Services Research
  • Ali Shemmari
  • Petter Nystrøm

Re-focused and re-energised

Q1: EBIT 7-8% better. Profitably > volume growth, the right move. Q2e set to be ATH: '24e-'25e EPS up 4-7%. '24e & '25e P/E 11.2x and 9.3x: Multiple expansion next, BUY.

 PRESS RELEASE

Avista Corp. Reports Financial Results for the First Quarter of 2024, ...

Avista Corp. Reports Financial Results for the First Quarter of 2024, Confirms 2024 Earnings Guidance First quarter consolidated earnings per diluted share of $0.91, in line with expectationsConfirms consolidated earnings guidance of $2.36 to $2.56 per diluted share SPOKANE, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Avista Corp. (NYSE: AVA) today announced financial results for the first quarter of 2024. Net income and earnings per diluted share for the first quarter of 2024 compared to the first quarter of 2023 are presented in the table below (dollars in thousands, except per-share data)...

 PRESS RELEASE

Hardman & Co Research on City of London Investment Group (CLIG): Posi...

Hardman & Co Research Hardman & Co Research on City of London Investment Group (CLIG): Positive inflows boost FUM 01-May-2024 / 11:58 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co Research on City of London Investment Group (CLIG): Positive inflows boost FUM   City of London has announced its FUM for 3Q’24. It was a positive quarter, with group FUM rising 5.5%, from $9.58bn to $10.10bn. The largest contribution came from a positive market backdrop: all the benchmark indices for CLIM strategies delivered positive returns over the...

 PRESS RELEASE

Olema Oncology to Participate in Upcoming Investor Conferences in May

Olema Oncology to Participate in Upcoming Investor Conferences in May SAN FRANCISCO, May 01, 2024 (GLOBE NEWSWIRE) -- (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that its management team will participate in the following upcoming investor conferences: BofA Securities Health Care Conference 2024Date: Tuesday, May 14, 2024, at 4:35 p.m. PTLocation: Encore Hotel in Las Vegas, NVFormat: Presentation H.C. Wainwright 2nd Annual BioC...

 PRESS RELEASE

Kamada to Announce First Quarter 2024 Financial Results and Host Confe...

Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 REHOVOT, Israel and HOBOKEN, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that it will release financial results for the first quarter ended March 31, 2024, prior to the open of the U.S. financial markets on Wednesday, May 8, 2024. Kamada management will host a...

 PRESS RELEASE

Astec Reports First Quarter 2024 Results

Astec Reports First Quarter 2024 Results First Quarter 2024 Overview (all comparisons are made to the corresponding prior year first quarter unless otherwise specified): Implied orders increased 2.4% sequentially from the fourth quarter.Backlog of $559.8 million as of March 31, 2024 approaching historical range.Net sales decreased 11.1% to $309.2 million. Gross margin of 24.9% decreased 70 basis points. Diluted EPS of $0.15 compared to $0.53; Adjusted EPS of $0.34 compared to $0.90. Federal highway and pavement contract awards increased 11% year-over-year.Record attendance at 2024 Wo...

 PRESS RELEASE

Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped V...

Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen New Variety 12-pack Features Hefe, Widberry Hefe, Apricot Hefe and Imperial Hefe PORTLAND, Ore., May 01, 2024 (GLOBE NEWSWIRE) -- (“”), brewers of The Original American Hefeweizen, and a subsidiary of Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY and TSX: TLRY), is launching a new Hefe Variety 12 Pack, showcasing a wide range of delicious wheat beer style brews. As creators of the American Wheat Beer style, Widmer Brothers has always been a leader in showcasing how wheat ...

 PRESS RELEASE

Akoustis Receives Two Design Wins with Tier-1 Network Infrastructure C...

Akoustis Receives Two Design Wins with Tier-1 Network Infrastructure Customer Tier-1 Customer to Use High-Performance Akoustis XBAW® Filters for Two Wi-Fi 7 Fixed Wireless Access Enterprise and Home Gateway PlatformsCompany Has Received Orders to Support Production Ramp Throughout Calendar Year 2024 Charlotte, N.C., May 01, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today the in...

 PRESS RELEASE

Dayforce Reports First Quarter 2024 Results

Dayforce Reports First Quarter 2024 Results Dayforce® recurring revenue of $337.2 million, up 24.3%, and excluding float revenue, up 23.0% Total revenue of $431.5 million, up 16.4% Operating profit of $40.7 million and adjusted operating profit of $109.1 million MINNEAPOLIS and TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- Dayforce, Inc. ("Dayforce" or the "Company") (NYSE:DAY) (TSX:DAY), a global leader in human capital management ("HCM") technology, today announced its financial results for the first quarter ended March 31, 2024. “I am pleased to report another strong quarter for Dayfor...

 PRESS RELEASE

Beyond Cancer Selected to Present on the Clinical Development of Ultra...

Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting Company to host an event featuring key opinion leaders (KOLs) on Friday, May 31st in Chicago to highlight the ongoing clinical development of UNO HAMILTON, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, today announced being selected to present on the clinica...

 PRESS RELEASE

Berry Corporation Reports First Quarter 2024 Financial and Operating R...

Berry Corporation Reports First Quarter 2024 Financial and Operating Results, Declares Dividend     DALLAS, May 01, 2024 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) announced first quarter 2024 results and declared a fixed dividend. The details for today’s earnings call and webcast are listed below. Quarterly Highlights & Recent Announcements Produced 25,400 boe/d, above the midpoint of 2024 annual guidance of 25,200 boe/dDeclared first quarter fixed dividends of $0.12 per shareAcquired all necessary 2024 California G...

 PRESS RELEASE

Bitfarms Provides April 2024 Production and Operations Update

Bitfarms Provides April 2024 Production and Operations Update - Earns 269 BTC in April 2024 -- Improves corporate energy efficiency 9% to 31 w/TH -- Tracking to 21 EH/s and 21 w/TH in 2024 with transformative fleet upgrade -- Expects VAT refund from Canada of US $23.7M -  This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 8, 2024, to its short form base shelf prospectus dated November 10, 2023. TORONTO, Ontario and BROSSARD, Québec, May 01, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/ TSX: BITF), a global vert...

 PRESS RELEASE

Axsome Therapeutics Recognizes May as Mental Health Awareness Month

Axsome Therapeutics Recognizes May as Mental Health Awareness Month NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today is joining the global community of mental health advocates, including Mental Health America, during May’s Mental Health Month to raise awareness of the importance of mental health as a key element of overall health. Axsome is committed to the millions of individuals living with mental health conditions...

 PRESS RELEASE

BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Re...

BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes SUNNYVALE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary endpoint results of the open label roll-in cohort of the CardiAMP® Cell Therapy in Chronic Myocardial Ischemia Trial. Study clinical cardiology leadership and members of the Executive Steering Committee, Dr. Carl Pepine, Professor of Medicine a...

 PRESS RELEASE

Plug Secures First International PEM Electrolyzer Certification in Kor...

Plug Secures First International PEM Electrolyzer Certification in Korea Final step completed to enable the commercial sale of Plug electrolyzer systems in Korea LATHAM, N.Y., May 01, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, secured the first international safety and performance certification in Korea for electrolyzer manufacturing, enabling the commercial sale of Plug electrolyzer systems in the Korean market. This achievement was completed through Plug's collaboration with SK E&S in the...

 PRESS RELEASE

Yum! Brands Reports First-Quarter Results

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Yum! Brands, Inc. (NYSE: YUM) today reported results for the first quarter ended March 31, 2024. Worldwide system sales, excluding foreign currency translation, grew 2%, with 6% unit growth and a 3% same-store sales decline. First-quarter GAAP operating profit declined 1% and first-quarter core operating profit grew 6%. First-quarter GAAP EPS was $1.10 and first-quarter EPS excluding Special Items was $1.15. First-quarter EPS includes negative after-tax impacts of $0.08 from investment losses and $0.03 from foreign currency translation. This press release fe...

 PRESS RELEASE

STAAR Surgical Strengthens Leadership Team with Appointments of Nancy ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced Nancy Sabin has been named Chief Marketing Officer and Nathaniel Sisitsky has been named General Counsel. Both will serve on the Company’s executive committee and report to Tom Frinzi, STAAR Surgical’s President and CEO. This press release features multimedia. View the full release here: Nancy Sabin, Chief Marketing Officer, STAAR Surgical (Photo: Business ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch